Showing results (251-260 of 322) with videos related to

Sort By:
Pageof 33
Leukemia & Lymphoma|June 8, 2019
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, et al.
Annals of Hematology|December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma reportJae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancerYoung Seok Kim, Sang Min Yoon, Eun Kyung Choi, et al.
The Korean Journal of Hematology|October 17, 2012
Clinical characteristics and outcomes of primary bone lymphoma in KoreaSo Yeon Kim, Dong-Yeop Shin, Seung-Sook Lee, et al.
Cancer Science|December 2, 2011
VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphomaMin Kyoung Kim, Cheolwon Suh, Hyun Sook Chi, et al.
Journal of Neuro-Oncology|March 16, 2004
Leptomeningeal carcinomatosis in gastric cancerJae-Lyun Lee, Yoon-Koo Kang, Tae-Won Kim, et al.
European Journal of Haematology|October 8, 2014
Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)Sung-Hoon Jung, Je-Jung Lee, Won Seog Kim, et al.
BMC Cancer|November 12, 2019
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphomaSeok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, et al.
Scientific Reports|July 2, 2020
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2Jin Roh, Hyungwoo Cho, Dok Hyun Yoon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphomaKyoung Ha Kim, Won Seog Kim, Seok Jin Kim, et al.
Pageof 33